Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suitWallstreetcn·Mar 16 at 09:28 PM688336+3.61%688513+0.81%
EASTON BIOPHARMACEUTICALS: The company's hydrochloride deoxycorticosterone injection and beraprost sodium tablets are expected to be selected for national centralized drug procurementZhitong·Oct 28, 2025 at 04:05 AM688513+0.81%
EASTON BIOPHARMACEUTICALS released its performance for the first three quarters, with a net profit attributable to the parent company of 220 million yuan, a year-on-year increase of 1.45%Zhitong·Oct 27, 2025 at 06:54 AM688513+0.81%
EASTON BIOPHARMACEUTICALS: Ailamod Tablets have obtained a drug registration certificateZhitong·Oct 17, 2025 at 04:13 AM688513+0.81%
SDKX and EASTON BIOPHARMACEUTICALS jointly expand the overseas market for Apalutamide tabletsZhitong·Oct 17, 2025 at 12:56 AM688513+0.81%688136+3.63%
EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificateZhitong·Sep 28, 2025 at 03:16 AM688513+0.81%
The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%Zhitong·Sep 25, 2025 at 08:33 PM300204+4.92%600276-1.04%
Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declinesZhitong·Sep 25, 2025 at 12:43 AM688166+3.49%301096+5.17%
EASTON BIOPHARMACEUTICALS: Hydrochloride Arolol Tablets have obtained a drug registration certificateZhitong·Sep 17, 2025 at 04:09 AM688513+0.81%
Innovative drug concept stocks show partial strength, Thalys hits the limit upZhitong·Sep 11, 2025 at 10:09 PM603127+3.72%061270.00%
EASTON BIOPHARMACEUTICALS: Pirfenidone tablets have obtained a drug registration certificateZhitong·Sep 5, 2025 at 03:37 AM688513+0.81%
The three major A-share indices opened mixed, with gold stocks strengthening36Kr·Sep 1, 2025 at 08:31 PM600489+5.07%688513+0.81%
EASTON BIOPHARMACEUTICALS: The hydrochloride of Nafamostat mesylate orally disintegrating tablets has obtained a drug registration certificateZhitong·Sep 1, 2025 at 04:23 AM688513+0.81%
A-share innovative drug concept stocks fluctuated upward, EASTON BIOPHARMACEUTICALS and BioKangtai rose over 10%, Thalys, Staidson BioPharm, ALK, and ZHIFEI-BIOL followed suitZhitong·Aug 24, 2025 at 08:41 PM300122+1.09%688513+0.81%
EASTON BIOPHARMACEUTICALS released its performance for the first half of the year, with a net profit attributable to the parent company of 137 million yuan, a decrease of 6.77%Zhitong·Aug 18, 2025 at 07:20 AM688513+0.81%
